• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

某些中枢性抗高血压药物的结构、pKa、亲脂性、溶解度、吸收及极性表面积的理论研究

Theoretical study of structure, pKa, lipophilicity, solubility, absorption, and polar surface area of some centrally acting antihypertensives.

作者信息

Remko Milan, Swart Marcel, Bickelhaupt F Matthias

机构信息

Comenius University, Department of Pharmaceutical Chemistry, Odbojarov 10, SK-832 32 Bratislava, Slovakia.

出版信息

Bioorg Med Chem. 2006 Mar 15;14(6):1715-28. doi: 10.1016/j.bmc.2005.10.020. Epub 2005 Nov 2.

DOI:10.1016/j.bmc.2005.10.020
PMID:16263295
Abstract

The methods of theoretical chemistry have been used to elucidate the molecular properties of the substituted imidazoline and oxazoline structures, a class of potent agonists and antagonists of imidazoline receptors. The geometries of various tautomers and isomers of 2-[2,6-dichlorophenylimino]imidazolidine (clonidine), 1-(N-dicyclopropylmethyl)amino-2-oxazoline (rilmenidine), 4-chloro-N-(4,5-dihydro-1H-imidazol-2yl)-6-methoxy-2-methyl-5-pyrimidinamine (moxonidine), N-(dicyclopropylmethyl)-4,5-dihydro-1H-pyrrol-2-amine (aminopyrroline), N-dicyclopropylmethyl-4,5-dihydrothiazol-2-amine (aminothiazoline), 4,5-dihydro-2-(2-methoxyphenyl)-1H-imidazole (compound_6), 4,5-dihydro-2-(3-methylthiophen-2-yl)-1H-imidazole (compound_7), N-(2-chloro-4-iodophenyl)-4,5-dihydro-5-methyl-3H-pyrrol-2-amine (LNP_911), N-amidino-3,5-diamino-6-chloropyrazine-carboxamide (amiloride), 2-(1,4-benzodioxan-2-yl)-2-imidazoline (idazoxan), (+/-)-2-(2-ethyl-2,3-dihydro-2-benzofuranyl)-2-imidazoline (efaroxan), (4-aminobutyl)guaninine (agmatine), and 1-methyl-9H-pyrido[3,4-b]indole (harmane) have been studied using Becke3LYP/6-31+G(d,p) and BP86/TZ2P DFT methods. The optimized geometries indicate that these molecules show a distinctly nonplanar configuration of the imidazoline and oxazoline moieties. In the gas-phase, rilmenidine and aminothiazoline exist in two forms (amino and imino), the amino tautomers being more stable by about 6 kJ/mol. The calculations showed, in agreement with experiments, that clonidine, moxonidine, and LNP_911 exist in a more stable imino tautomer. The tautomer containing the amino group is by about 30 kJ/mol less stable. Computations that include the effect of solvation indicated that also in water the relative stability order of individual tautomers (amino and imino forms) is preserved. The computed pKa values varied between 6.7 and 9.0, and correlate well with the available experimental pKa's found in the literature. Among the clinically useful antihypertensives moxonidine exhibits the lowest basicity in water. At pH = 7.4 only about 50% of this drug exists in ionized form. The available experimental partition coefficients of compounds investigated are best reproduced by the CLOGP method. The computed partition coefficients varied between -1.80 (agmatine) and 5.35 (LNP_911) (CLOGP). Clonidine, moxonidine, and rilmenidine are moderately lipophilic compounds with lipophilicities between these two extreme values. The computed solubilities (about 0.1-4 g/L) show that the imidazoline and oxazoline derivatives studied have very low water solubility. The analysis of molecular descriptors defined by Lipinski has shown that most of the compounds studied obey 'rule of five'. Amiloride and agmatine 'outlets' exhibit also the lowest absorption. Therefore, in the early stages of the design of ligands acting on imidazoline binding sites, it is becoming more important to determine the pKa, lipophilicity, water solubility, polar surface area, absorption, and other physicochemical properties associated with a drug, before synthetic work is undertaken, with the aim of avoiding the synthesis of compounds that are predicted to have poor biopharmaceutical characteristics.

摘要

理论化学方法已被用于阐明取代咪唑啉和恶唑啉结构的分子性质,这是一类咪唑啉受体的强效激动剂和拮抗剂。使用Becke3LYP/6 - 31 + G(d,p)和BP86/TZ2P密度泛函理论(DFT)方法研究了2 - [2,6 - 二氯苯基亚氨基]咪唑烷(可乐定)、1 - (N - 二环丙基甲基)氨基 - 2 - 恶唑啉(利美尼定)、4 - 氯 - N - (4,5 - 二氢 - 1H - 咪唑 - 2 - 基)-6 - 甲氧基 - 2 - 甲基 - 5 - 嘧啶胺(莫索尼定)、N - (二环丙基甲基)-4,5 - 二氢 - 1H - 吡咯 - 2 - 胺(氨基吡咯啉)、N - 二环丙基甲基 - 4,5 - 二氢噻唑 - 2 - 胺(氨基噻唑啉)、4,5 - 二氢 - 2 - (2 - 甲氧基苯基)-1H - 咪唑(化合物_6)、4,5 - 二氢 - 2 - (3 - 甲基噻吩 - 2 - 基)-1H - 咪唑(化合物_7)、N - (2 - 氯 - 4 - 碘苯基)-4,5 - 二氢 - 5 - 甲基 - 3H - 吡咯 - 2 - 胺(LNP_911)、N - 脒基 - 3,5 - 二氨基 - 6 - 氯吡嗪 - 甲酰胺(阿米洛利)、2 - (1,4 - 苯并二恶烷 - 2 - 基)-2 - 咪唑啉(伊达唑胺)、(±)-2 - (2 - 乙基 - 2,3 - 二氢 - 2 - 苯并呋喃基)-2 - 咪唑啉(依发罗新)、(4 - 氨基丁基)胍(胍丁胺)和1 - 甲基 - 9H - 吡啶并[3,4 - b]吲哚(哈尔满)的各种互变异构体和异构体的几何结构。优化后的几何结构表明,这些分子的咪唑啉和恶唑啉部分呈现出明显的非平面构型。在气相中,利美尼定和氨基噻唑啉以两种形式(氨基和亚氨基)存在,氨基互变异构体更稳定,大约稳定6 kJ/mol。计算结果与实验一致,表明可乐定、莫索尼定和LNP_911以更稳定的亚氨基互变异构体形式存在。含氨基的互变异构体稳定性低约30 kJ/mol。包含溶剂化效应的计算表明,在水中各互变异构体(氨基和亚氨基形式)的相对稳定性顺序也得以保留。计算得到的pKa值在6.7至9.0之间,与文献中可用的实验pKa值相关性良好。在临床有用的抗高血压药物中,莫索尼定在水中的碱性最低。在pH = 7.4时,该药物仅约50%以离子形式存在。所研究化合物的可用实验分配系数通过CLOGP方法能得到最佳重现。计算得到的分配系数在 - 1.80(胍丁胺)至5.35(LNP_911)(CLOGP)之间变化。可乐定、莫索尼定和利美尼定是中等亲脂性化合物,亲脂性介于这两个极值之间。计算得到的溶解度(约0.1 - 4 g/L)表明,所研究的咪唑啉和恶唑啉衍生物的水溶性非常低。对由Lipinski定义的分子描述符的分析表明,所研究的大多数化合物遵循“五规则”。阿米洛利和胍丁胺“例外”,其吸收也最低。因此,在设计作用于咪唑啉结合位点的配体的早期阶段,在进行合成工作之前确定与药物相关的pKa、亲脂性、水溶性、极性表面积、吸收及其他物理化学性质变得越发重要,目的是避免合成预计具有不良生物药剂学特性的化合物。

相似文献

1
Theoretical study of structure, pKa, lipophilicity, solubility, absorption, and polar surface area of some centrally acting antihypertensives.某些中枢性抗高血压药物的结构、pKa、亲脂性、溶解度、吸收及极性表面积的理论研究
Bioorg Med Chem. 2006 Mar 15;14(6):1715-28. doi: 10.1016/j.bmc.2005.10.020. Epub 2005 Nov 2.
2
Theoretical study of gas-phase acidity, pKa, lipophilicity, and solubility of some biologically active sulfonamides.一些生物活性磺胺类药物的气相酸度、pKa、亲脂性和溶解度的理论研究
Bioorg Med Chem. 2004 Oct 15;12(20):5395-403. doi: 10.1016/j.bmc.2004.07.049.
3
Molecular structure and stability of perindopril erbumine and perindopril L-arginine complexes.培哚普利叔丁胺盐与培哚普利L-精氨酸复合物的分子结构与稳定性
Eur J Med Chem. 2009 Jan;44(1):101-8. doi: 10.1016/j.ejmech.2008.03.012. Epub 2008 Mar 27.
4
Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 1. Synthesis and biological activities of N-benzyl-N'-(arylalkyl)-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines .II型糖尿病大鼠模型中对葡萄糖稳态有活性的咪唑啉衍生物的设计与合成。1. N-苄基-N'-(芳基烷基)-2-(4',5'-二氢-1'H-咪唑-2'-基)哌嗪的合成及生物活性
J Med Chem. 1997 Nov 7;40(23):3793-803. doi: 10.1021/jm9608624.
5
Synthesis and biological evaluation of pyrrolinic isosteres of rilmenidine. Discovery of cis-/trans-dicyclopropylmethyl-(4,5-dimethyl-4,5-dihydro-3H-pyrrol-2-yl)-amine (LNP 509), an I1 imidazoline receptor selective ligand with hypotensive activity.利美尼定的吡咯啉类似物的合成及生物学评价。具有降压活性的I1咪唑啉受体选择性配体顺式/反式-二环丙基甲基-(4,5-二甲基-4,5-二氢-3H-吡咯-2-基)-胺(LNP 509)的发现。
J Med Chem. 2001 May 10;44(10):1588-93. doi: 10.1021/jm001111b.
6
Testing conception of engagement of imidazoline receptors in imidazoline drugs effects on isolated rat heart atria.测试咪唑啉受体参与咪唑啉类药物对离体大鼠心房作用的概念。
J Physiol Pharmacol. 2009 Mar;60(1):131-42.
7
QSAR study of imidazoline antihypertensive drugs.咪唑啉类抗高血压药物的定量构效关系研究
Bioorg Med Chem. 2008 Aug 1;16(15):7134-40. doi: 10.1016/j.bmc.2008.06.051. Epub 2008 Jun 28.
8
[Conformational study of drugs which affect I1-imidazoline receptors].[影响I1-咪唑啉受体的药物的构象研究]
Ceska Slov Farm. 2002 Jul;51(4):196-9.
9
The effects of imidazoline agents on the aggregation of human platelets.咪唑啉类药物对人血小板聚集的影响。
J Pharm Pharmacol. 2004 Feb;56(2):213-20. doi: 10.1211/0022357022593.
10
Insights into structure-activity relationships from lipophilicity profiles of pyridin-2(1H)-one analogs of the cardiotonic agent milrinone.从强心剂米力农的吡啶-2(1H)-酮类似物的亲脂性概况深入了解构效关系。
Eur J Pharm Sci. 2005 Sep;26(1):78-86. doi: 10.1016/j.ejps.2005.05.001.

引用本文的文献

1
Analysing the effect caused by increasing the molecular volume in M1-AChR receptor agonists and antagonists: a structural and computational study.分析M1-乙酰胆碱受体激动剂和拮抗剂中分子体积增加所引起的效应:一项结构与计算研究。
RSC Adv. 2024 Mar 14;14(13):8615-8640. doi: 10.1039/d3ra07380g.
2
DFT Study on the Electronic Properties, Spectroscopic Profile, and Biological Activity of 2-Amino-5-trifluoromethyl-1,3,4-thiadiazole with Anticancer Properties.具有抗癌特性的2-氨基-5-三氟甲基-1,3,4-噻二唑的电子性质、光谱特征及生物活性的密度泛函理论研究
ACS Omega. 2020 Nov 13;5(46):30073-30087. doi: 10.1021/acsomega.0c04474. eCollection 2020 Nov 24.
3
Pharmacophoric features of drugs with guanylurea moiety: an electronic structure analysis.
含胍基脲部分药物的药效团特征:电子结构分析。
J Mol Model. 2013 Apr;19(4):1865-74. doi: 10.1007/s00894-012-1743-2. Epub 2013 Jan 17.
4
In silico screening for antibiotic escort molecules to overcome efflux.计算机筛选抗生素外排泵抑制剂
J Mol Model. 2011 Nov;17(11):2863-72. doi: 10.1007/s00894-011-0978-7. Epub 2011 Feb 8.
5
3,5-Bis(benzylidene)-1-[4-2-(morpholin-4-yl)ethoxyphenylcarbonyl]-4-piperidone hydrochloride: a lead tumor-specific cytotoxin which induces apoptosis and autophagy.3,5-双(苯亚甲基)-1-[4-2-(吗啉-4-基)乙氧基羰基]哌啶盐酸盐:一种潜在的肿瘤特异性细胞毒素,可诱导细胞凋亡和自噬。
Bioorg Med Chem Lett. 2010 Feb 1;20(3):912-7. doi: 10.1016/j.bmcl.2009.12.076. Epub 2009 Dec 24.
6
Topological polar surface area: a useful descriptor in 2D-QSAR.拓扑极性表面积:二维定量构效关系中的一个有用描述符。
Curr Med Chem. 2009;16(1):21-41. doi: 10.2174/092986709787002817.